Philips BioTel Heart

Philips BioTel Heart is a United States based biotechnology, health care and medical devices company that has positioned itself as "The Cardiac Data Company." Leveraging its innovative, patented technology, the company gained FDA approval for its core monitoring technology, distinguishing itself as the pioneer in offering real-time, heartbeat-by-heartbeat, ECG monitoring, analysis, and response, whether at home or away, on a 24/7/365 basis. Founded in 1999, the company focuses on the diagnosis and monitoring of cardiac arrhythmias, catering to cardiologists and electrophysiologists by providing a wide range of solutions, including the Mobile Cardiac Outpatient Telemetry™ (“MCOT™”) service, among others. This also encompasses the provision of International normalized ratio (“INR”) monitoring, which measures blood coagulation and is prescribed for patients on long-term anticoagulation therapy. Notably, Philips BioTel Heart is in a phase of expansion and development, with no publicly disclosed recent investment activities or investors.